Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 48.10
-2.00 (-3.99%)
Jul 14, 2026, 1:24 PM CST
TPEX:7427 Revenue
In the year 2025, Great Novel Therapeutics Biotech & Medicals had annual revenue of 1.21M TWD, down -28.49%. Great Novel Therapeutics Biotech & Medicals had revenue of 582.00K in the half year ending December 31, 2025, with 561.36% growth.
Revenue
1.21M
Revenue Growth
-28.49%
P/S Ratio
1,698.50
Revenue / Employee
54.77K
Employees
22
Market Cap
2.05B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.21M | -480.00K | -28.49% |
| Dec 31, 2024 | 1.69M | -3.17M | -65.26% |
| Dec 31, 2023 | 4.85M | 4.31M | 798.15% |
| Dec 31, 2022 | 540.00K | -90.00K | -14.29% |
| Dec 31, 2021 | 630.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.07B |
| Synbio Tech | 1.02B |
| HeXun Biosciences | 293.23M |
| G&E Herbal Biotechnology | 261.21M |
| Sunny Pharmtech | 253.01M |
| Gwo Xi Stem Cell Applied Technology Co. , | 187.02M |
| GlycoNex Incorporation | 36.35M |
| Anti-Microbial Savior BioteQ | 706.00K |